biOasis Technologies Inc
XTSX:BTI

Watchlist Manager
biOasis Technologies Inc Logo
biOasis Technologies Inc
XTSX:BTI
Watchlist
Price: 0.01 CAD Market Closed
Updated: May 18, 2024

biOasis Technologies Inc
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

biOasis Technologies Inc
Operating Expenses Peer Comparison

Comparables:
ZYME
RPTX
FUSN
AUPH
EDT

Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
biOasis Technologies Inc
XTSX:BTI
Operating Expenses
-CA$3.3m
CAGR 3-Years
24%
CAGR 5-Years
1%
CAGR 10-Years
4%
Zymeworks Inc
NYSE:ZYME
Operating Expenses
-$214.1m
CAGR 3-Years
2%
CAGR 5-Years
-20%
CAGR 10-Years
N/A
Repare Therapeutics Inc
NASDAQ:RPTX
Operating Expenses
-$167.4m
CAGR 3-Years
-46%
CAGR 5-Years
-67%
CAGR 10-Years
N/A
Fusion Pharmaceuticals Inc
NASDAQ:FUSN
Operating Expenses
-$101.3m
CAGR 3-Years
-39%
CAGR 5-Years
-59%
CAGR 10-Years
N/A
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Operating Expenses
-$238.6m
CAGR 3-Years
-10%
CAGR 5-Years
-32%
CAGR 10-Years
-40%
Spectral Medical Inc
TSX:EDT
Operating Expenses
-CA$12.4m
CAGR 3-Years
-5%
CAGR 5-Years
-16%
CAGR 10-Years
1%

See Also

What is biOasis Technologies Inc's Operating Expenses?
Operating Expenses
-3.3m CAD

Based on the financial report for Nov 30, 2022, biOasis Technologies Inc's Operating Expenses amounts to -3.3m CAD.

What is biOasis Technologies Inc's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
4%

Over the last year, the Operating Expenses growth was 8%. The average annual Operating Expenses growth rates for biOasis Technologies Inc have been 24% over the past three years , 1% over the past five years , and 4% over the past ten years .